| Year |
Citation |
Score |
| 2023 |
Nichols DP, Morgan SJ, Skalland M, Vo AT, Van Dalfsen JM, Singh SB, Ni W, Hoffman LR, McGeer K, Heltshe SL, Clancy JP, Rowe SM, Jorth PK, Singh PK. Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density but lung infections generally persist. The Journal of Clinical Investigation. PMID 36976651 DOI: 10.1172/JCI167957 |
0.3 |
|
| 2018 |
Roesch EA, Nichols DP, Chmiel JF. Inflammation in cystic fibrosis: An update. Pediatric Pulmonology. PMID 29999593 DOI: 10.1002/Ppul.24129 |
0.388 |
|
| 2015 |
Nichols DP, Chmiel JF. Inflammation and its genesis in cystic fibrosis. Pediatric Pulmonology. 50: S39-56. PMID 26335954 DOI: 10.1002/ppul.23242 |
0.37 |
|
| 2015 |
Taylor-Cousar JL, Wiley C, Felton LA, St Clair C, Jones M, Curran-Everett D, Poch K, Nichols DP, Solomon GM, Saavedra MT, Accurso FJ, Nick JA. Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 228-36. PMID 25466700 DOI: 10.1016/J.Jcf.2014.10.006 |
0.332 |
|
| 2014 |
Chandler JD, Min E, Huang J, McElroy CS, Dickerhof N, Mocatta T, Fletcher AA, Evans CM, Liang L, Patel M, Kettle AJ, Nichols DP, Day BJ. Anti-Inflammatory and Anti-Microbial Effects of Thiocyanate in a Cystic Fibrosis Mouse Model. American Journal of Respiratory Cell and Molecular Biology. PMID 25490247 DOI: 10.1165/Rcmb.2014-0208Oc |
0.304 |
|
| 2010 |
Taylor-Cousar JL, Von Kessel KA, Young R, Nichols DP. Potential of anti-inflammatory treatment for cystic fibrosis lung disease. Journal of Inflammation Research. 3: 61-74. PMID 22096358 |
0.353 |
|
| 2009 |
Nichols DP, Ziady AG, Shank SL, Eastman JF, Davis PB. The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. American Journal of Physiology. Lung Cellular and Molecular Physiology. 297: L828-36. PMID 19700644 DOI: 10.1152/Ajplung.00171.2009 |
0.345 |
|
| 2008 |
Perez A, van Heeckeren AM, Nichols D, Gupta S, Eastman JF, Davis PB. Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium. American Journal of Physiology. Lung Cellular and Molecular Physiology. 295: L303-13. PMID 18556801 DOI: 10.1152/Ajplung.90276.2008 |
0.322 |
|
| 2008 |
Nichols DP, Konstan MW, Chmiel JF. Anti-inflammatory therapies for cystic fibrosis-related lung disease. Clinical Reviews in Allergy & Immunology. 35: 135-53. PMID 18546078 DOI: 10.1007/S12016-008-8081-2 |
0.392 |
|
| 2008 |
Nichols D, Chmiel J, Berger M. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clinical Reviews in Allergy & Immunology. 34: 146-62. PMID 17960347 DOI: 10.1007/S12016-007-8039-9 |
0.333 |
|
| Show low-probability matches. |
